Biotechnology Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter – Corcept Therapeutics (NASDAQ:CORT) Read more
Biotechnology What’s Going On With Stress Hormone Modulator-Focused Corcept Therapeutics’ Stock Friday? – Corcept Therapeutics (NASDAQ:CORT) Read more
